Steven J. Burton
Presidente presso ProMetic BioSciences Ltd.
Profilo
Steven J.
Burton is currently the President & Chief Scientific Officer at Astrea Bioseparations Ltd.
and the President at ProMetic BioSciences Ltd.
He previously served as the Chief Executive Officer at Liminal BioSciences, Inc.
Posizioni attive di Steven J. Burton
| Società | Posizione | Inizio |
|---|---|---|
ProMetic BioSciences Ltd.
 ProMetic BioSciences Ltd. Miscellaneous Commercial ServicesCommercial Services ProMetic BioSciences Ltd. operates as a biopharmaceutical company. The company was founded by Christopher Robin Low and is headquartered in Laval, Canada. | Presidente | - |
Astrea Bioseparations Ltd.
 Astrea Bioseparations Ltd. Medical SpecialtiesHealth Technology Astrea Bioseparations Ltd. develops and manufactures affinity purification technology. It specializes in affinity chromatography and bioseparations, specifically purification of proteins and the elimination of contaminants including pathogens. The company was founded in 1987 and is headquartered in Cambridge, the United Kingdom. | Presidente | 14/06/2021 |
Precedenti posizioni note di Steven J. Burton
| Società | Posizione | Fine |
|---|---|---|
| LIMINAL BIOSCIENCES INC. | Presidente | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| LIMINAL BIOSCIENCES INC. | Health Technology |
| Aziende private | 2 |
|---|---|
ProMetic BioSciences Ltd.
ProMetic BioSciences Ltd. Miscellaneous Commercial ServicesCommercial Services ProMetic BioSciences Ltd. operates as a biopharmaceutical company. The company was founded by Christopher Robin Low and is headquartered in Laval, Canada. | Commercial Services |
Astrea Bioseparations Ltd.
Astrea Bioseparations Ltd. Medical SpecialtiesHealth Technology Astrea Bioseparations Ltd. develops and manufactures affinity purification technology. It specializes in affinity chromatography and bioseparations, specifically purification of proteins and the elimination of contaminants including pathogens. The company was founded in 1987 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Steven J. Burton
